2019 UMB ICTR Internal KL2 scholar from School of Dentistry leads school-wide effort to minimize the risk of COVID-19 infection from dental patient to care providers.
While the nation is undergoing unprecedent pandemic and opioid crises, Internal KL2 Scholars from UMB’s Institute of Clinical Translational Research (ICTR) are thriving and meeting these health care challenges.
Providing care to patients while protecting health care providers is of paramount importance during pandemic. Dr. Sydnee Chavis, an assistant professor and a 2019 ICTR Internal KL2 scholar from School of Dentistry, is leading a school-wide effort to minimize the risk of COVID-19 infection via aerosols and droplets from dental patient to care providers. Her findings, “Can Extraoral Suction Units Minimize Droplet Spatter During A Simulated Dental Procedures?” recently was accepted by the Journal of American Dental Association and will be published soon.
UMB’s Institute of Clinical Translational Research (ICTR) is the first Universitywide interdisciplinary hub for clinical and translational research. Directed by Dr. Stephen Davis, MBBS, FRCP, FACE, MACP, ICTR provides shared resources to our research community through its four cores (biostatistics, community and collaboration, drug discovery and development, and informatics), consultations, grants, and educational opportunities.